切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - SUMOylation - AChR

16件产品中的 1-10

页面
每页
清除全部
  1. BQCA
    C3869 BQCA
    Target: AChR
    Summary: M1毒蕈碱乙酰胆碱受体(mAChR)的正变构调节剂
      ≥30.9 mg/mL
      insoluble in H2O
  2. Pancuronium dibromide
    B1612 Pancuronium dibromide
    中文名: 泮库溴铵
    Target: AChR
    Summary: AChR拮抗剂
      ≥36.63 mg/mL
      ≥49.4 mg/mL
  3. Trospium chloride
    B1616 Trospium chloride
    中文名: 曲司氯铵
    Target: AChR
    Summary: 抗毒蕈碱剂
      ≥21.4 mg/mL
      ≥29.25 mg/mL
  4. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  5. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  6. Tolterodine tartrate
    B1620 Tolterodine tartrate
    中文名: 酒石酸托特罗定
    Target: AChR
    Summary: 竞争性毒蕈碱受体拮抗剂
      ≥23.78 mg/mL
      insoluble in H2O
  7. MLN4924
    B1036 MLN4924
     5 Citation
    Target: NAE|Ubiquitin-activating Enzyme E1|SUMOylation
    Summary: NAE抑制剂
      ≥22.18 mg/mL
      insoluble in H2O
  8. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  9. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  10. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O

16件产品中的 1-10

页面
每页